News

Zusduri: Revolutionizing Bladder Cancer Treatment Through Targeted Local Delivery

Zusduri is the first FDA-approved targeted, non-surgical treatment for recurrent low-grade, intermediate-risk non–muscle invasive bladder cancer. It delivers mitomycin C directly into the bladder using RTGel® technology, which turns from liquid to gel at body temperature. This allows the drug to stay in contact with the bladder wall for hours, maximizing local effect while minimizing […]

Zusduri: Revolutionizing Bladder Cancer Treatment Through Targeted Local Delivery Read More »

Artificial Intelligence in Complex Liver Cancer Surgery: Precision Oncological Resection

AI is transforming liver cancer surgery by improving precision, planning, and safety. It helps surgeons better understand the liver’s complex anatomy, allowing more accurate tumor removal while preserving healthy tissue. This leads to safer procedures and better overall outcomes for patients. Before surgery, AI converts CT and MRI scans into detailed 3D models, enabling “virtual

Artificial Intelligence in Complex Liver Cancer Surgery: Precision Oncological Resection Read More »